The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

Please provide your email address to receive an email when new articles are posted on . LNZ100 improved near vision by at least two lines in 91% of participants. LNZ100 also improved distance vision.

In Lenz Therapeutics’ new eye drop campaign, Sarah Jessica Parker serves as a brand ambassador for the over-40 audience.

Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) revealed topline results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for ...

Please provide your email address to receive an email when new articles are posted on . Visual acuity at distances of 0.3 m, 0.5 m and 0.7 m significantly improved. Users experienced higher ...

PASADENA, Calif.--(BUSINESS WIRE)--Near Intelligence, Inc. (Nasdaq: NIR) (“Near” or the “Company”), a global leader in privacy-led data intelligence on people and places, today announced that its ...

Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical ...